Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc > NCIB Repurchase Stopped in July?

<< Previous

Bullboard Posts

Next >>

Comment by GoldenInvestoron Jul 28, 2023 6:30pm

119 Views

Post# 35562517

RE:RE:RE:NCIB Repurchase Stopped in July?

CC, I like your comments.

Are you invested in GUD?! Or just like watching history repeat itself. In building a pharma co.?

- it's been a long slow building process

so Far You are right that the SP has done nothing...

however, what did management say at outset?

Have you seen The increase in revenues?

what do you think of that trajectory?